To complement excellence in scientific research, successful commercialisation requires research teams to have a strong understanding of their target markets, the specific problems their technologies address, the competitive landscape, and the ability to...
Therapeutic Oligonucleotides for Cancer
Development of a modern generation of therapeutic oligonucleotides for targeting and destroying cancer at the genetic level.
Lead: Prof. Andrew Kellett
